References
- National Asthma Education and Prevention Program. Expert Panel II: Guidelines for the diagnosis and management of asthma. National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD 1997
- The British Guidelines on Asthma Management. 1995 Review and position statement. Thorax 1997; 52: S1
- Molina J M, Rowland F S. Stratospheric sink for chlorofluoromethanes: Chlorine atom catalysed destruction of ozone. Nature 1974; 249: 810
- Environmental effects of ozone depletion. 1991 update. Panel report pursuant to Article 6 of the Montreal Protocol on substances that deplete the Ozone layer under the auspices of the United Nations Environment Programme. J Photochem Photobiol B 1992; 13: 187
- Bleecker E R, Tinkelman D G, Ramsdell J, Ekholm B P, Klinger N M, Colice G L, Slade H B. Proventil HFA provides bronchodilation comparable to Ventolin over 12 weeks of regular use in asthmatics. Chest 1998; 113: 283
- Tinkelman D G, Bleecker E R, Ramsdell J, Ekholm B P, Klinger N M, Colice G L, Slade H B. Proventil HFA and Ventolin have similar safety profiles during regular use. Chest 1998; 113: 290
- American Thoracic Society. Standardization of spirometry. Am J Respir Crit Care Med 1995; 152: 1107
- Polgar G, Promadhat V. Pulmonary Function Testing in Children: Techniques and Standards. W.B. Saunders, Philadelphia 1971
- Kleerup E C, Tashkin D P, Cline A C, Ekholm B P. Cumulative dose response study of non-CFC propellant HFA-134a salbutamol sulfate metered dose inhaler in patients with asthma. Chest 1996; 109: 702
- Ramsdell J W, Colice G L, Ekholm B P, Klinger N M. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma. Ann Allergy Asthma Immunol 1998; 81: 593
- Parameswaran K N, Inman M D, Ekholm B E, Morris M M, Summers E, O'Byrne P M, Hargreave F E. Protection against methacholine bronchoconstriction to assess relative potency of inhaled R2-agonist. Am J Respir Crit Care Med 1999; 160: 354
- Drazen J M, Israel E, Boushey H A, et al. Comparison of regularly scheduled with as needed use of albuterol in mild asthma. N Engl J Med 1996; 335: 841
- Schuster A, Kozlik R, Reinhardt D. Influence of short- and long term inhalation of salbutamol on lung function and beta-adrenoceptors of mononuclear blood cells in asthmatic children. Eur J Pediatr 1991; 150: 209
- Jartti T T, Kaila T J, Tahyanained K UO, Kuusela T A, Vanto T T, Valimaki I AT. Altered cardiovascular autonomic regulation after 2-week inhaled salbutamol treatment in asthmatic children. Eur J Pediatr 1997; 156: 883
- Kozlik-Feldmann R, von Berg A, Berdel D, Reinhardt D. Long term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma. Eur J Med Res 1996; 1: 465
- Skoner D P, Boltansky H, Kobayashi R H, Pearlman D S, Shapiro G, Harrison J E, Trochelmann L M, Lorber R R. Extended release albuterol in the treatment of 6–12-year old asthmatic children. Ann Allergy Asthma Immunol 1996; 76: 462